The Novumed team is now part of EY
Since the 1st of October 2016 the Novumed team has become part of the strategy division of Ernst & Young (EY). EY is one of the leading global tax and advisory firms. At EY we may now offer a full range of services from strategy development to implementation and financial assessments in order to fully service your business needs.
The experienced management consultants and advisory team support life science companies, industry groups and investors in the preparation and implementation of market strategies, innovation strategies and strategic financial transactions.
Novumed consultants and advisory team is comprised of biochemists, medical doctors and economists with global experience in international strategy consulting, healthcare and investment banking. Our team has first-class academic backgrounds and top tier professional experience in order to meet the high demands of our clients.
Novumed is one of the few firms with truly international operations. We are able to offer projects across the globe, where you will work with industry leaders.
Clear market focus on pharma/biotech and medtech/diagnostics
Team of highly qualified scientists, MDs and MBAs with outstanding backgrounds
Good understanding of technologies and sciences as well as business strategies and finance
International scope with offices in the US and Europe, as well as project experience in most of the world's established and emerging markets
High quality standards in project management and professional methodologies
"We would prefer to work with a specialized international firm like Novumed where we will receive a greater level of senior management attention than we can from the large advisory firms."
"Historically we have not worked with consultants but now that we are supported by Novumed, our Business Development team is clearly more efficient."
"Novumed is truly independent when selecting their research sources. Some market research firms recycle the data generated by their CI department."
"Novumed's superior documentation and analysis clearly distinguishes them from other consulting firms, which has convinced us to use Novumed on additional projects in the future."
"After Novumed's consulting staff did an excellent job in analyzing the gastroenterology market, Novumed's advisory experts took over to support the out-licensing of a Phase II product in the US market."